Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: guidelines for technology and protocols.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
Teriflunomide : a novel oral treatment for relapsing multiple sclerosis.
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
Demyelinating neuropathy and autoimmune hemolytic anemia in a patient with pancreatic cancer.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Optic neuritis in neuromyelitis optica.
Reduced habituation of the retinal ganglion cell response to sustained pattern stimulation in multiple sclerosis patients.
Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study.
Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
Longitudinal follow-up of vision in a neuromyelitis optica cohort.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Hydrocephalus in neuromyelitis optica.
Vitamin D and multiple sclerosis.
An epidemiological study of neuromyelitis optica in Isfahan.
[Applications of Optical Coherence Tomography (OCT) in Neuro-ophthalmology.]
Pages
« first
‹ previous
…
356
357
358
359
360
361
362
363
364
…
next ›
last »